These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 10072302

  • 1. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.
    Bezard E, Gross CE, Fournier MC, Dovero S, Bloch B, Jaber M.
    Exp Neurol; 1999 Feb; 155(2):268-73. PubMed ID: 10072302
    [Abstract] [Full Text] [Related]

  • 2. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 3. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 15; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 4. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
    Callier S, Morissette M, Grandbois M, Pélaprat D, Di Paolo T.
    Synapse; 2001 Aug 24; 41(2):131-8. PubMed ID: 11400179
    [Abstract] [Full Text] [Related]

  • 6. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 24; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
    Watanabe Y, Himeda T, Araki T.
    Med Sci Monit; 2005 Jan 24; 11(1):RA17-23. PubMed ID: 15614202
    [Abstract] [Full Text] [Related]

  • 8. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL.
    Neurotoxicology; 2004 Sep 24; 25(5):761-9. PubMed ID: 15288507
    [Abstract] [Full Text] [Related]

  • 9. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.
    Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW.
    J Neurosci Res; 2004 Aug 01; 77(3):378-90. PubMed ID: 15248294
    [Abstract] [Full Text] [Related]

  • 10. Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.
    Walters TL, Irwin I, Delfani K, Langston JW, Janson AM.
    Exp Neurol; 1999 Mar 01; 156(1):62-70. PubMed ID: 10192777
    [Abstract] [Full Text] [Related]

  • 11. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
    Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, Wang X.
    Eur J Pharmacol; 2009 Sep 01; 617(1-3):33-40. PubMed ID: 19545563
    [Abstract] [Full Text] [Related]

  • 12. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
    Ferger B, Leng A, Mura A, Hengerer B, Feldon J.
    J Neurochem; 2004 May 01; 89(4):822-33. PubMed ID: 15140182
    [Abstract] [Full Text] [Related]

  • 13. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN, Ryoo H, Cox C, Lu W.
    J Comp Neurol; 1995 Nov 20; 362(3):400-10. PubMed ID: 8576447
    [Abstract] [Full Text] [Related]

  • 14. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
    Muñoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL.
    Neuropharmacology; 2006 Jul 20; 51(1):112-20. PubMed ID: 16678218
    [Abstract] [Full Text] [Related]

  • 15. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.
    Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351
    [Abstract] [Full Text] [Related]

  • 16. Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection.
    Stephenson D, Ramirez A, Long J, Barrezueta N, Hajos-Korcsok E, Matherne C, Gallagher D, Ryan A, Ochoa R, Menniti F, Yan J.
    J Neurosci Methods; 2007 Jan 30; 159(2):291-9. PubMed ID: 16949674
    [Abstract] [Full Text] [Related]

  • 17. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 30; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 18. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 30; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 19. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T.
    Synapse; 2001 Jun 01; 40(3):225-34. PubMed ID: 11304760
    [Abstract] [Full Text] [Related]

  • 20. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S, Morissette M, Morin N, Di Paolo T.
    J Neuroendocrinol; 2005 Aug 01; 17(8):509-17. PubMed ID: 16011487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.